PRESS RELEASE published on 10/07/2025 at 22:00, 1 month 28 days ago Inventiva présentera plusieurs abstracts lors du congrès AASLD The Liver Meeting® 2025 Inventiva présentera plusieurs abstracts au congrès AASLD The Liver Meeting® 2025. Présentation d'une comparaison histologie numérique sur lame biopsies NATiV3 et pathologie numérique de lanifibranor préclinique Pathologie Numérique Inventiva Lanifibranor AASLD The Liver Meeting 2025 Histologie Numérique
BRIEF published on 10/01/2025 at 08:35, 2 months 4 days ago Andrew Obenshain nommé PDG d'Inventiva Transition De Leadership Développement De Médicaments Inventiva Traitement MASH André Obenshain
BRIEF published on 10/01/2025 at 08:35, 2 months 4 days ago Andrew Obenshain Appointed as CEO of Inventiva Leadership Transition Drug Development Inventiva MASH Treatment Andrew Obenshain
PRESS RELEASE published on 10/01/2025 at 08:30, 2 months 4 days ago Inventiva annonce la nomination d’Andrew Obenshain au poste de Directeur Général Inventiva annonce la nomination d'Andrew Obenshain au poste de Directeur Général, marquant une transition de leadership stratégique pour la société biopharmaceutique spécialisée dans le traitement de la MASH Directeur Général Transition De Leadership Inventiva MASH Andrew Obenshain
PRESS RELEASE published on 10/01/2025 at 08:30, 2 months 4 days ago Inventiva Appoints Andrew Obenshain as Chief Executive Officer Inventiva appoints Andrew Obenshain as Chief Executive Officer, succeeding Frédéric Cren, to lead company's growth and prepare for potential commercialization in the United States Chief Executive Officer Inventiva MASH Frédéric Cren Andrew Obenshain
BRIEF published on 09/24/2025 at 22:05, 2 months 10 days ago Inventiva organise un événement pour analystes et investisseurs Phase 3 Événement Inventiva MASH Lanifibranor
BRIEF published on 09/24/2025 at 22:05, 2 months 10 days ago Inventiva organizes an event for analysts and investors Event Phase 3 Inventiva MASH Lanifibranor
PRESS RELEASE published on 09/24/2025 at 22:00, 2 months 10 days ago Inventiva to Host Analyst and Investor Event on October 8, 2025 Inventiva to host analyst and investor event on October 8, 2025 featuring updates on lanifibranor and key MASH trends. Renowned experts to share insights on MASH landscape Inventiva Lanifibranor Analyst Event MASH Trends Expert Insights
PRESS RELEASE published on 09/24/2025 at 22:00, 2 months 10 days ago Inventiva organise un événement analystes et investisseurs le 8 octobre 2025 Inventiva organisera un événement pour analystes et investisseurs le 8 octobre 2025 à New York, présentant lanifibranor, traitement de la stéatohépatite (MASH) Événement Inventiva MASH Analystes Lanifibranor
Published on 12/05/2025 at 02:35, 9 hours 7 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 10 hours 42 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 12 hours 37 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 12 hours 42 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 11:08, 33 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 12/05/2025 at 10:30, 1 hour 12 minutes ago Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 1 hour 27 minutes ago Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 2 hours 2 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 08:45, 2 hours 57 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 2 hours 57 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 3 hours ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 17 hours 28 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 17 hours 42 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025